Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-12 Purchase | 2024-11-14 5:21 pm | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 1,000 | $12.75 | $12,750 | 1,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-06-17 Option Award | 2025-06-18 4:44 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 20,100 | $0 | 20,100 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:39 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 20,100 | $0 | 20,100 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:35 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 20,100 | $0 | 20,100 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:30 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 20,100 | $0 | 20,100 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:25 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 20,100 | $0 | 20,100 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:19 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Heffernan Michael Thomas Director | 29,500 | $0 | 29,500 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:13 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 20,100 | $0 | 20,100 (Direct) | View |
2025-06-17 Option Award | 2025-06-18 4:08 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 40,200 | $0 | 40,200 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 8:06 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,167 | $0 | 9,500 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:55 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 3,167 | $0 | 9,500 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:44 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 3,167 | $0 | 9,500 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:37 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 3,167 | $0 | 9,500 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:30 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 3,167 | $0 | 9,500 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:22 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 3,167 | $0 | 10,500 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:11 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 24,200 | $0 | 65,321 (Direct) | View |
2025-03-28 Tax Withholding | 2025-04-01 4:11 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 7,285 | $8.46 | 65,321 (Direct) | View |
2025-03-28 Exercise | 2025-04-01 4:01 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 64,867 | $0 | 176,873 (Direct) | View |
2025-03-28 Tax Withholding | 2025-04-01 4:01 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 17,787 | $8.46 | 176,873 (Direct) | View |
2025-03-25 Option Award | 2025-03-26 4:07 pm | N/A 2035-03-25 | Avalo Therapeutics Inc. | AVTX | Heffernan Michael Thomas Director | 50,000 | $0 | 50,000 (Direct) | View |
2025-01-28 Option Award | 2025-01-30 5:51 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 100,000 | $0 | 100,000 (Direct) | View |
2025-01-28 Option Award | 2025-01-30 5:43 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 163,000 | $0 | 163,000 (Direct) | View |
2025-01-28 Option Award | 2025-01-30 5:31 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR CEO and Chairman of the Board | 411,000 | $0 | 411,000 (Direct) | View |
2025-01-28 Option Award | 2025-01-30 5:20 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 155,000 | $0 | 155,000 (Direct) | View |
2025-01-01 Option Award | 2025-01-03 4:06 pm | N/A 2035-01-01 | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 150,000 | $0 | 150,000 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 5:04 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 34,100 | $0 | 34,100 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:56 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 34,100 | $0 | 34,100 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:47 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 34,100 | $0 | 34,100 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:36 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 34,100 | $0 | 34,100 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:27 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 34,100 | $0 | 34,100 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:19 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 34,100 | $0 | 34,100 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:11 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 259,300 | $0 | 259,306 (Direct) | View |
2024-08-13 Option Award | 2024-08-14 4:00 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR CEO and Chairman of the Board | 695,000 | $0 | 695,060 (Direct) | View |
2024-07-15 Option Award | 2024-07-16 4:23 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 234,000 | $0 | 234,000 (Direct) | View |
2024-06-24 Option Award | 2024-06-25 4:08 pm | N/A 2034-06-24 | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |